Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141, Powder for Solution for Subcutaneous Administration, 250 µg (GEROPHARM LLC, Russia) and Enplate®, Powder for Solution for Subcutaneous Administration, 250 µg (Amgen Europe B.V. ., Netherlands) in Healthy Volunteers With a Single Subcutaneous Injection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05652595
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:52.274278+00:00
Published At
2022-12-15T00:00:00+00:00
Record Updated At
2022-12-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pharmacodynamics", "Pharmacokinetics", "Bioequivalence"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-12-15"
protocolSection.identificationModule.nctId
"NCT05652595"
protocolSection.identificationModule.officialTitle
"Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141, Powder for Solution for Subcutaneous Administration, 250 \u00b5g (GEROPHARM LLC, Russia) and Enplate\u00ae, Powder for Solution for Subcutaneous Administration, 250 \u00b5g (Amgen Europe B.V. ., Netherlands) in Healthy Volunteers With a Single Subcutaneous Injection"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pharmacodynamics (protocolSection.conditionsModule.conditions)
  • Pharmacokinetics (protocolSection.conditionsModule.conditions)
  • Bioequivalence (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.